Related Experiment Video
Updated: Feb 12, 2026

08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
Zachary Field1, Andreas Zori2, Vikas Khullar2
1Liver Unit, Florida State University College of Medicine, Tallahassee, FL.
ACG Case Reports Journal
|March 27, 2018
Summary
This case study details a rare instance of malignant peritoneal mesothelioma (MPM) presenting as mucinous ascites. Diagnosis was confirmed via colonoscopy, highlighting a unique primary tumor site in the colon.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Malignant peritoneal mesothelioma (MPM) is a rare cancer, distinct from the more common pleural mesothelioma.
- While asbestos exposure is a known risk factor for pleural mesothelioma, peritoneal mesothelioma has varied etiologies.
- Peritoneal mesothelioma accounts for 6-10% of all mesothelioma cases.
Observation:
- A 46-year-old male presented with mucinous ascites, an unusual clinical manifestation.
- Diagnostic colonoscopy with biopsies revealed the underlying cause.
- The patient's presentation and the tumor's origin were highly unique.
Findings:
- The patient was diagnosed with malignant peritoneal mesothelioma (MPM).
- The primary tumor site was identified within the colon.
- This represents one of only four documented cases of MPM originating from the colon.
Implications:
- This case expands the understanding of rare MPM presentations and colon cancer associations.
- Highlights the importance of thorough diagnostic workups, including colonoscopy, for unexplained ascites.
- Contributes to the limited literature on colonic primary malignant peritoneal mesothelioma, aiding future research and clinical management.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
884
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
884
Peritoneal Dialysis I: Introduction and Procedure
3.5K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.5K
Peritoneal Dialysis III: Nursing Management
909
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
909
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
551
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
551

